Literature DB >> 18491103

Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla.

F Fischbach1, T Schirmer, M Thormann, T Freund, J Ricke, H Bruhn.   

Abstract

This comparative study of tumour patients and volunteers aimed at differentiating liver parenchyma from neoplastic lesions by using localised (1)H MRS at 3.0 T as an adjunct to MRI. In total 186 single-voxel proton spectra of the liver were acquired at 3.0 T using the body transmit receive coil. Consecutive stacks of breath-hold spectra were acquired in the PRESS technique at a short echo time of 35 ms and a repetition time of 2,000 ms. Processing of the spectra included spectral alignment with the software package SAGE and quantitative processing with LCModel. The resulting metabolite concentrations were presented in arbitrary units relative to the internal water. In general, the spectra showed four main groups of resonances originating from the methyl protons (0.8-1.1 ppm) and methylene protons of the lipids (1.1-1.5 ppm; 2.0-2.2 ppm) as well as the methyl protons of choline-containing compounds (CCC) at 3.2 ppm. Overall, the CCC and lipid values in malignant liver tumours showed no significant differences to liver parenchyma. On average, total lipid measurements in normal liver parenchyma increased with age, while those of the CCC did not show pertinent changes. Significant differences between the contents of CCC in malignant liver tumours and normal liver parenchyma were not observed, because in patients and volunteers normal liver tissue showed a large variability in the content of CCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491103     DOI: 10.1007/s00330-008-1040-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla.

Authors:  R Bartha; D J Drost; R S Menon; P C Williamson
Journal:  Magn Reson Med       Date:  2000-08       Impact factor: 4.668

Review 2.  Cramér-Rao bounds: an evaluation tool for quantitation.

Authors:  S Cavassila; S Deval; C Huegen; D van Ormondt; D Graveron-Demilly
Journal:  NMR Biomed       Date:  2001-06       Impact factor: 4.044

3.  Echo-train STIR MRI of the liver: comparison of breath-hold and non-breath-hold imaging strategies.

Authors:  J P Earls; N M Rofsky; D R DeCorato; G A Krinsky; J C Weinreb
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

4.  The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy.

Authors:  T A Smith; J Glaholm; M O Leach; L Machin; V R McCready
Journal:  NMR Biomed       Date:  1991-12       Impact factor: 4.044

5.  Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.

Authors:  S G Cho; M Y Kim; H J Kim; Y S Kim; W Choi; S H Shin; K C Hong; Y B Kim; J H Lee; C H Suh
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

6.  Abnormal liver metabolism in cancer patients detected by (31)P MR spectroscopy.

Authors:  P C Dagnelie; P E Sijens; D J Kraus; A S Planting; P v van Dijk
Journal:  NMR Biomed       Date:  1999-12       Impact factor: 4.044

7.  In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.

Authors:  Yu-Ting Kuo; Chun-Wei Li; Chao-Yun Chen; Jochi Jao; Ding-Kwo Wu; Gin-Chang Liu
Journal:  J Magn Reson Imaging       Date:  2004-05       Impact factor: 4.813

Review 8.  NMR studies of phospholipid metabolism in hepatic lymphoma.

Authors:  R M Dixon
Journal:  NMR Biomed       Date:  1998-11       Impact factor: 4.044

9.  Human primary brain tumour metabolism in vivo: a phosphorus magnetic resonance spectroscopy study.

Authors:  T A Cadoux-Hudson; M J Blackledge; B Rajagopalan; D J Taylor; G K Radda
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

10.  A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.

Authors:  T A Smith; J Glaholm; M O Leach; L Machin; D J Collins; G S Payne; V R McCready
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  22 in total

1.  3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?

Authors:  Rossano Girometti
Journal:  World J Hepatol       Date:  2015-07-28

2.  Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy.

Authors:  Boris Guiu; Romaric Loffroy; Jean-Michel Petit; Serge Aho; Douraied Ben Salem; David Masson; Patrick Hillon; Jean-Pierre Cercueil; Denis Krause
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

3.  MR Spectra of Normal Adult Testes and Variations with Age: Preliminary Observations.

Authors:  Athina C Tsili; Loukas G Astrakas; Alexandra Ntorkou; Dimitrios Giannakis; Sotirios Stavrou; Vasilios Maliakas; Nikolaos Sofikitis; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2015-10-16       Impact factor: 5.315

Review 4.  In vivo magnetic resonance spectroscopy of liver tumors and metastases.

Authors:  E G W ter Voert; L Heijmen; H W M van Laarhoven; A Heerschap
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

Review 5.  Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Authors:  Roberto García-Figueiras; Sandra Baleato-González; Anwar R Padhani; Laura Oleaga; Joan C Vilanova; Antonio Luna; Juan Carlos Cobas Gómez
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

6.  Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy.

Authors:  Susanne Bonekamp; Jialin Shen; Nouha Salibi; Hong C Lai; Jeff Geschwind; Ihab R Kamel
Journal:  J Comput Assist Tomogr       Date:  2011 Mar-Apr       Impact factor: 1.826

7.  Liver metabolite concentrations measured with 1H MR spectroscopy.

Authors:  Ronald Ouwerkerk; Roderic I Pettigrew; Ahmed M Gharib
Journal:  Radiology       Date:  2012-08-13       Impact factor: 11.105

8.  Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

Authors:  Daniel A Feeney; Leslie C Sharkey; Susan M Steward; Katherine L Bahr; Michael S Henson; Daisuke Ito; Timothy D O'Brien; Carl R Jessen; Brian D Husbands; Antonella Borgatti; Jaime F Modiano
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  3.0 T proton magnetic resonance spectroscopy of the liver: quantification of choline.

Authors:  Li Xu; Bo Liu; Yan Huang; Xian Liu; Si-Wei Zhang; Xue-Gang Xin; Jin-Zhi Zheng
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 10.  Multiparametric MR Imaging in Abdominal Malignancies.

Authors:  Antonio Luna; Shivani Pahwa; Claudio Bonini; Lidia Alcalá-Mata; Katherine L Wright; Vikas Gulani
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.